These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12385404)

  • 1. International application of the incidence rate/window period model.
    Glynn SA; Kleinman SH; Wright DJ; Busch MP;
    Transfusion; 2002 Aug; 42(8):966-72. PubMed ID: 12385404
    [No Abstract]   [Full Text] [Related]  

  • 2. Further enhancement of the safety of human plasma derivatives.
    Lamb C
    Transfusion; 2002 Aug; 42(8):973-4. PubMed ID: 12385405
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis.
    Busch MP
    Transfusion; 2006 Sep; 46(9):1624-40. PubMed ID: 16965593
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimated risk of transfusion-transmitted viral infections in Spain.
    Alvarez M; Oyonarte S; Rodríguez PM; Hernández JM
    Transfusion; 2002 Aug; 42(8):994-8. PubMed ID: 12385409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of risk of window-period transmission of blood-borne viral diseases in Quebec.
    Germain M; Gélinas S; Delage G
    CMAJ; 2004 Mar; 170(7):1077-8. PubMed ID: 15051677
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000.
    Pillonel J; Laperche S; Saura C; Desenclos JC; Couroucé AM;
    Transfusion; 2002 Aug; 42(8):980-8. PubMed ID: 12385407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010.
    Lucky TT; Seed CR; Keller A; Lee J; McDonald A; Ismay S; Wand H; Wilson DP
    Transfusion; 2013 Nov; 53(11):2751-62. PubMed ID: 23461827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma.
    Wagner SJ; Friedman LI; Dodd RY
    Transfus Med Rev; 1991 Jan; 5(1):18-32. PubMed ID: 1802274
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of using different blood donor subpopulations and models on the estimation of transfusion transmission residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in Zimbabwe.
    Mapako T; Janssen MP; Mvere DA; Emmanuel JC; Rusakaniko S; Postma MJ; van Hulst M
    Transfusion; 2016 Jun; 56(6 Pt 2):1520-8. PubMed ID: 26801952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Viral safety measures of plasma for transfusion and applicability in Spain].
    Pereira A
    Med Clin (Barc); 2007 Oct; 129(12):458-68. PubMed ID: 17953912
    [No Abstract]   [Full Text] [Related]  

  • 11. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.
    Dodd RY; Notari EP; Stramer SL
    Transfusion; 2002 Aug; 42(8):975-9. PubMed ID: 12385406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
    Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
    Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
    Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
    JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monetary blood donation incentives and the risk of transfusion-transmitted infection.
    Eastlund T
    Transfusion; 1998 Sep; 38(9):874-82. PubMed ID: 9738629
    [No Abstract]   [Full Text] [Related]  

  • 16. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy.
    Tosti ME; Solinas S; Prati D; Salvaneschi L; Manca M; Francesconi M; Ciuffreda M; Girelli G; Mele A
    Br J Haematol; 2002 Apr; 117(1):215-9. PubMed ID: 11918558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the residual risk of transfusion-transmitted viruses: mini-pool or single-donation NAT?
    Roth WK; Seifried E
    Transfusion; 2001 Jun; 41(6):845-7. PubMed ID: 11399831
    [No Abstract]   [Full Text] [Related]  

  • 18. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reconsideration of the risk of transmitting infectious diseases by blood transfusion].
    Janot C; Streiff F
    Ann Fr Anesth Reanim; 1989; 8(3):199-203. PubMed ID: 2675686
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of transfusion-transmissible viral infections in first-time US blood donors by donation site.
    Wang B; Schreiber GB; Glynn SA; Nass CC; Smith JW; Higgins MJ; Hutching ST; Wright DJ; McEntire RL; Murphy EL;
    Transfusion; 2003 Jun; 43(6):705-12. PubMed ID: 12757520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.